GLP Watchdog

Fridays vs Henry Meds

Neither Fridays nor Henry Meds has an FDA warning letter on record. On compounded semaglutide injection, Fridays costs $576 less a year at standing rates: $249 a month against $297 a month at Henry Meds. It is one of two products the two sell at comparable terms.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Fridays / Henry Meds

Fridays logo

Fridays

5.8/10

Henry Meds logo

Henry Meds

5.6/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
Lowest standing price
$249/moCompounded semaglutide injection
$249/moCompounded oral semaglutide
States
No state list published
No state list published
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Fridays
Visit Henry Meds

Neither Fridays nor Henry Meds pays us. Links to them earn nothing. Scores: Fridays 5.8, Henry Meds 5.6. How we are paid

What the record shows

  1. 01

    Neither Fridays nor Henry Meds has an FDA warning letter on record.

  2. 02

    Fridays names four pharmacies. Henry Meds names no compounding pharmacy in our record.

  3. 03

    On compounded semaglutide injection, Fridays costs $576 less a year at standing rates: $249 a month against $297 a month at Henry Meds. It is one of two products the two sell at comparable terms.

  4. 04

    Only Fridays lists a price for brand-name semaglutide pen and brand-name tirzepatide pen. Only Henry Meds lists a price for compounded oral semaglutide.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Fridays

Henry Meds

Compounded semaglutide injection

$249/moLower

$2,988 a year

$297/mo

$3,564 a year

Compounded tirzepatide injection

$359/mo

$4,308 a year

$349/moLower

$4,188 a year

Brand-name semaglutide pen

$1,498/mo

$17,976 a year

Not sold or not priced
Brand-name tirzepatide pen

$1,828/mo

$21,936 a year

Not sold or not priced
Compounded oral semaglutide
Not sold or not priced

$249/mo

$2,988 a year

Price includes
Medication, clinician visits, coaching
Medication, clinician visits, shipping
Cancel any time
Yes, stated
Yes, stated
Minimum term
None on the monthly plan; 3, 6 and 12-month plans are prepaid
None on monthly plans; longer plans are offered for some treatments
Refunds
Fees are non-refundable except for medical disqualification, billing errors or where the law requires
Subscription fees generally non-refundable; medication is final sale once shipped
Early-exit fee
Not stated
Yes

Read off each seller’s own pages. Fridays: October 30, 2026. Henry Meds: October 30, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Fridays

5.8/10
  • $576 a year less on compounded semaglutide injection
  • Sells brand-name semaglutide pen and brand-name tirzepatide pen, which Henry Meds does not price
  • Names its compounding pharmacy
Visit Fridays

The case for Henry Meds

5.6/10
  • $120 a year less on compounded tirzepatide injection
  • Sells compounded oral semaglutide, which Fridays does not price
  • Names no compounding pharmacy
Visit Henry Meds

Scores

Fridays 5.8 · Henry Meds 5.6 out of 10. Six weighted parts.

Value25%

3.4A
vs
B
3.4

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

3.0A
vs
B
3.0

Trust & Safety15%

5.5A
vs
B
4.0

Accessibility10%

5.0A
vs
B
5.0

Support10%

7.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Fridays vs Henry Meds: questions

Neither Fridays nor Henry Meds has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Fridays names four pharmacies. Henry Meds names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Fridays, by $576 a year at standing rates. Fridays: $249 a month, about $2,988 a year. Henry Meds: $297 a month, about $3,564 a year.
Fridays states you can cancel at any time; refunds: fees are non-refundable except for medical disqualification, billing errors or where the law requires. Henry Meds states you can cancel at any time; refunds: subscription fees generally non-refundable; medication is final sale once shipped.
Neither Fridays nor Henry Meds pays us. Links to them earn nothing. Scores: Fridays 5.8, Henry Meds 5.6.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks